Erythrocyte Function and Pathophysiology
Erythrocyte Function and Pathophysiology is a research topic within Physiology. Science Explorer counts 48k research works in it since 1950. 18.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the role of mechanosensitive ion channels, particularly Piezo1 and Piezo2, in various physiological processes such as mechanotransduction, erythrocyte function, sensory neuron response, and erythropoiesis. It also explores the implications of these channels in diseases related to erythrocytes, sensory perception, and cellular mechanosensation.
- Piezo1
- Piezo2
- mechanotransduction
- erythrocyte
- mechanosensation
- ion channels
- membrane
- sensory neurons
- erythropoiesis
- apoptosis
- Research works
- 48k fractional, since 1950
- In the world top 10%
- 8.9k per year above
- Top-10% rate
- 18.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +11% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Erythrocyte Function and Pathophysiology research?
By volume, the United States and China publish the most (1.2k and 774 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.2k works
- 2 China 774 works
- 3 India 297 works
- 4 Japan 197 works
- 5 Germany 180 works
- 6 France 162 works
- 7 Italy 159 works
- 8 United Kingdom 143 works
- 9 Russia 141 works
- 10 Canada 84 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Erythrocyte Function and Pathophysiology research?
By volume in 2022–2025, Inserm publishes the most Erythrocyte Function and Pathophysiology research, followed by Harvard University and Chinese Academy of Medical Sciences & Peking Union Medical College.
By volume, 2022–2025
- 1 InsermFrance 17 works
- 2 Harvard UniversityUnited States 17 works
- 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 17 works
- 4 Yale UniversityUnited States 15 works
- 5 University of PennsylvaniaUnited States 14 works
- 6 Sun Yat-sen UniversityChina 13 works
- 7 University of California San DiegoUnited States 13 works
- 8 Washington University in St. LouisUnited States 12 works
- 9 Centre National de la Recherche ScientifiqueFrance 12 works
- 10 Stanford UniversityUnited States 12 works
Who are the leading researchers in Erythrocyte Function and Pathophysiology?
The most-cited researchers publishing on Erythrocyte Function and Pathophysiology include George Em Karniadakis.
- 1 George Em Karniadakis United States 6.3k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Erythrocyte Function and Pathophysiology research done?
The largest centres of Erythrocyte Function and Pathophysiology research in 2022–2025 are Beijing (China), Paris (France), Shanghai (China) and Moscow (Russia). Among places with at least 20 works in it, it is an unusually large share of all research in Bethesda.
Largest cities, 2022–2025
Where it is the local speciality
- BethesdaUS · 33.6 works6.2×
Location quotient: how much more of its research is in Erythrocyte Function and Pathophysiology than the world average.
Where is the best place to study Erythrocyte Function and Pathophysiology?
Among universities, judged by research, University of Colorado Anschutz Medical Campus, University of Leeds and Harvard University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of Colorado Anschutz Medical CampusUnited States | 61.7 | 28.8% | 8.2× | 10 | +160.8% |
| 2 | University of LeedsUnited Kingdom | 57.4 | 36.6% | 3.8× | 9 | +154.9% |
| 3 | Harvard UniversityUnited States | 54.5 | 28.7% | 3.1× | 17 | -13.3% |
| 4 | University of PennsylvaniaUnited States | 51.9 | 35.0% | 3.5× | 14 | -12.6% |
| 5 | Sichuan UniversityChina | 49.5 | 40.7% | 1.6× | 12 | +52.1% |
| 6 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 48.9 | 17.9% | 4.0× | 17 | +65.4% |
| 7 | University of Maryland, BaltimoreUnited States | 47.7 | 28.0% | 7.3× | 10 | -12.2% |
| 8 | Yale UniversityUnited States | 47.1 | 20.9% | 3.5× | 15 | +47.5% |
| 9 | Case Western Reserve UniversityUnited States | 46.1 | 12.6% | 7.4× | 11 | +87.0% |
| 10 | Sun Yat-sen UniversityChina | 45.5 | 30.6% | 1.9× | 13 | +44.8% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Erythrocyte Function and Pathophysiology research growing?
Output in 2018–2022 was 11% higher than in 2013–2017, peaking in 2022. The fastest-growing topics are Erythrocyte Function and Pathophysiology.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.